Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
Follow MTD
Mettler-Toledo International, Inc. (MTD) P/S ratio
As of 16 October 2026, Mettler-Toledo International, Inc. (MTD) trades at a P/S ratio of 7.9×. Over the past ten years it has ranged from 3.2× (September 2015) to 10.8× (December 2021); the current reading is higher than 79% of that period. That is above the Diagnostics & Research industry median of 4.4× and above the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 7.1× | 6.42% |
| FY2024 | 6.7× | (4.23%) |
| FY2023 | 7.0× | (16.52%) |
| FY2022 | 8.4× | (20.55%) |
| FY2021 | 10.6× | 19.68% |
| FY2020 | 8.8× | 36.20% |
| FY2019 | 6.5× | 33.34% |
| FY2018 | 4.9× | (17.77%) |
| FY2017 | 5.9× | 32.31% |
| FY2016 | 4.5× | 13.94% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 6.2× | (0.60%) |
| Mar 2026 | 6.3× | (12.34%) |
| Dec 2025 | 7.1× | 11.72% |
| Sep 2025 | 6.4× | 1.64% |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| LH Labcorp Holdings Inc. compare | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 2.3× |
| IQV IQVIA Holdings Inc. compare | 2.6× |
| A Agilent Technologies, Inc. compare | 6.6× |
| MTD Mettler-Toledo International, Inc. | 7.9× |
| ILMN Illumina, Inc. compare | 8.8× |
| WAT Waters Corporation compare | 9.2× |
| IDXX IDEXX Laboratories, Inc. compare | 9.7× |
| GH Guardant Health, Inc. compare | 17.8× |
| Diagnostics & Research industry median | 4.4× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on MTD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement